A Food and Drug Administration advisory panel declared on Tuesday that a common oral decongestant, phenylephrine, is not effective in relieving a stuffy nose, leaving many consumers and pharmaceutical companies with questions heading into the cold and flu season.
The Food and Drug Administration (FDA) ruled Tuesday that a key drug in popular decongestants is ineffective, which one Canadian group of doctors has known for years.